Your browser doesn't support javascript.
loading
Crizotinib therapy for congenital embryonal rhabdomyosarcoma associated with an ATIC-ALK gene fusion.
Akane, Yusuke; Yamamoto, Masaki; Takebayashi, Akira; Hamada, Ryo; Igarashi, Keita; Emori, Makoto; Sugita, Shintaro; Takada, Kohichi; Hasegawa, Tadashi; Tsugawa, Takeshi.
Afiliação
  • Akane Y; Department of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Yamamoto M; Department of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Takebayashi A; Department of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Hamada R; Department of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Igarashi K; Department of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Emori M; Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Sugita S; Department of Surgical Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Takada K; Department of Medical Oncology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Hasegawa T; Department of Surgical Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Tsugawa T; Department of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, Japan.
Pediatr Blood Cancer ; 71(9): e31148, 2024 Sep.
Article em En | MEDLINE | ID: mdl-38884266

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas de Fusão Oncogênica / Rabdomiossarcoma Embrionário / Crizotinibe / Quinase do Linfoma Anaplásico Limite: Female / Humans / Male / Newborn Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas de Fusão Oncogênica / Rabdomiossarcoma Embrionário / Crizotinibe / Quinase do Linfoma Anaplásico Limite: Female / Humans / Male / Newborn Idioma: En Ano de publicação: 2024 Tipo de documento: Article